Innovating Works
NEOpTTL: Innovative approach to an Individualised T-Cell Immunotherapy for cancer, using Personalised Tumour... NEOGAP THERAPEUTICS AB tramitó un HORIZON EUROPE: HORIZON-EIC-2023-ACCELERATOR-01 NEOGAP has developed a groundbreaking personalised adoptive T cell therapy for treating solid tumours based on two proprietary technologies:...
2023-11-21 - 2026-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.